Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Antagonism Effects on HPG Axis in Healthy Subjects
NCT04975347Phase 1Completed
- Start
- Jun 2022
- Primary completion
- Aug 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of naloxone in reproductive system disease (2 arms). Primary endpoints: Average change in Luteinizing Hormone (LH) pulse frequency and Difference in Average LH Pulse Frequency at 12 hours. Started Jun 2022; status: completed.
02
Drugs
naloxone
03
Conditions
reproductive system disease
Beyond the preview
Go deeper on NCT04975347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04975347.